Raffa Wealth Management’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-150
Closed -$815 1211
2025
Q2
$815 Hold
150
﹤0.01% 916
2025
Q1
$521 Hold
150
﹤0.01% 950
2024
Q4
$1.54K Sell
150
-40
-21% -$498 ﹤0.01% 743
2024
Q3
$2.58K Hold
190
﹤0.01% 570
2024
Q2
$2.47K Buy
+190
New +$2.35K ﹤0.01% 669

Other funds holding THRD

Raffa Wealth Management's THRD Position: Q3 2025 in Review

Raffa Wealth Management sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 150 shares — an estimated $815 sold.

Raffa Wealth Management first reported a position in THRD in Q2 2024 and held it in 5 quarters. The position peaked at $2.58K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Raffa Wealth Management reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Raffa Wealth Management sold 150 Third Harmonic Bio shares in Q3 2025, an estimated $815.
  • Raffa Wealth Management first reported a position in Third Harmonic Bio in Q2 2024 and held it in 5 quarters.
  • Raffa Wealth Management's Third Harmonic Bio position peaked at $2.58K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Raffa Wealth Management's 13F filing for Q3 2025, filed 27 Jul 2026.